Skip to the main content

Andrew Ian Henry Russell, 15th Duke of Bedford

Buckinghamshire Website
Cheque Size$1M to $50M
Stages7
Industries15
Markets20
Stated Portfolio1

About Andrew Ian Henry Russell, 15th Duke of Bedford

The 15th Duke of Bedford is a British aristocrat and investor with interests in various sectors, including real estate and agriculture. He manages the Bedford Estates, which encompass significant land holdings in Bloomsbury, London, and Woburn Abbey in Bedfordshire. These estates have been owned by the Russell family since 1669 and have been developed into residential, commercial, and leisure properties over the centuries. The Duke is committed to preserving the heritage of these estates while ensuring their sustainable development. In addition to real estate, the Duke has diversified his investments into agriculture, technology, and biotechnology. He has been involved in funding biotech startups, such as Dragonfly Therapeutics, a company developing drugs to stimulate immune responses against cancer. This investment reflects his interest in innovative sectors beyond traditional land-based assets. The Duke's approach combines traditional land management with modern investment strategies to enhance the value and sustainability of his family's holdings. The Duke's wealth is substantial, with estimates placing his net worth at £884 million as of May 2025. This wealth is derived from the extensive property holdings and successful investments managed by the Bedford Estates. His investment philosophy emphasizes long-term stewardship, capital preservation, and a commitment to enhancing the value of his assets through strategic development and diversification.

Geographical Focus

African markets1

Other stated markets19

United StatesUnited KingdomCanadaGermanyJapanAustraliaChinaFranceItalyDenmarkSwitzerlandSpainIrelandNetherlandsNew ZealandSwedenBelgiumNorwayFinland

Requirements

Long-term capital preservation, Sustainable development practices, Diversification across sectors, Commitment to heritage and community engagement, Interest in innovative and high-growth industries

Stated Portfolio1

Dragonfly Therapeutics

As reported by the investor. We hold no profile for this company, so it is printed as stated rather than linked.

Is this you?

Claim this investor profile to manage your firm's information.

Claim this profile
Report an error

Contact

Profile

TypeFamily Office
CityBuckinghamshire
Minimum Cheque$1M
Maximum Cheque$50M